To further confirm whether proguanil inhibits the progress of BC cells by targeting EGFR, we first compared the inhibitory activity of proguanil on T24 (EGFR high expression) and J82 (EGFR low expression) by MTT, colony formation, and transwell assays. The gene discussed is EGFR; the disease is breast cancer.